Research Topics
Species | James F WinchesterSummaryAffiliation: RenalTech International Country: USA Publications
| Collaborators
|
Detail Information
Publications
The next step from high-flux dialysis: application of sorbent technologyJames F Winchester
RenalTech International, New York, NY 10021, USA
Blood Purif 20:81-6. 2002..Extensive clinical studies are underway to demonstrate the clinical utility and safety of adding routinely a sorbent hemoperfusion device to hemodialysis...
Beta-2 microglobulin in ESRD: an in-depth reviewJames F Winchester
RenalTech International, LLC, New York, NY 10021, USA
Adv Ren Replace Ther 10:279-309. 2003..There seems to be a relative risk reduction in mortality when patients are treated with dialysis membranes that have a higher clearance of beta-2 microglobulin...
Sorbents in acute renal failure and the systemic inflammatory response syndromeJames F Winchester
RenalTech International, New York, NY 10021, USA
Blood Purif 21:79-84. 2003....
Removal of middle molecules with sorbentsJames F Winchester
RenalTech International, LLC, 320 East 65th St, 116 New York, NY 10021, USA
Artif Cells Blood Substit Immobil Biotechnol 30:547-54. 2002
Special clinical problems in geriatric patientsJames F Winchester
RenalTech International, New York, NY 10021, USA
Semin Dial 15:116-20. 2002..In the event of overwhelming illness and the patient's perception of the futility of continuation of dialysis, cessation of dialysis must be approached in a humane, considerate, and compassionate manner...
Dialysis and hemoperfusion in poisoningJames F Winchester
RenalTech International, SUNY Downstate Medical Center, 320 East 65th Street 116, New York, NY 10021, USA
Adv Ren Replace Ther 9:26-30. 2002..Tables of drugs removed by both techniques are given for guidance. These tables will be updated regularly on the Advances in Renal Replacement Therapy website...
Sorbent hemoperfusion in end-stage renal disease: an in-depth reviewJames F Winchester
RenalTech International, SUNY Downstate Medical Center, 320 East 65th Street 116, New York, NY 10021, USA
Adv Ren Replace Ther 9:19-25. 2002..Clinical application of hemoperfusion devices containing these sorbents is early in its development. Studies related to hemoperfusion in uremia are discussed in detail...
Sorbents in acute renal failure and end-stage renal disease: middle molecule and cytokine removalJames F Winchester
RenalTech International, New York, NY 10021, USA
Blood Purif 22:73-7. 2004..Sorbent devices added to hemodialysis, or the use of such devices alone in inflammatory states, including sepsis, ARF, cardiopulmonary bypass, pre-explantation of donor organs and ESRD, are being studied...
The impact of residual renal function on hospitalization and mortality in incident hemodialysis patientsZachary Z Brener
Department of Medicine, Nephrology Division, Beth Israel Medical Center, New York, NY 10003, USA
Blood Purif 31:243-51. 2011..Few data are available on the impact of residual renal function (RRF) on mortality and hospitalization in hemodialysis (HD) patients. The objective of our study was to compare clinical outcomes for HD patients with and without RRF...
Metformin-induced lactic acidosis and acute pancreatitis precipitated by diuretic, celecoxib, and candesartan-associated acute kidney dysfunctionPat Audia
Beth Israel Medical Center, Nephrology and Hypertension, New York, New York 10003, USA
Clin Toxicol (Phila) 46:164-6. 2008..The kidney injury caused the accumulation of metformin, leading to lactic acidosis and acute pancreatitis. Sodium bicarbonate hemodialysis not only improved the metabolic abnormalities but also hastened the removal of metformin...
Extracorporeal removal of toxinsPallavi K Tyagi
Division of Nephrology and Hypertension, Department of Medicine, Beth Israel Medical Center, New York, New York, USA
Kidney Int 74:1231-3. 2008..TESS data do not separate continuous renal replacement therapy from hemodialysis, and not all poisonings were reported in this system. Nonetheless, these trends are useful to the nephrology community...
Intoxications amenable to extracorporeal removalJames F Winchester
Division of Nephrology and Hypertension, Beth Israel Medical Center, New York, NY 10003, USA
Adv Chronic Kidney Dis 18:167-71. 2011..This article will discuss the principles of drug removal, the indications for dialysis, and give a brief outline of poisons amenable to dialysis...
Guidelines for guidelinesRichard Amerling
Beth Israel Medical Center, 350 East 17th Street, New York, NY 10003, USA
Blood Purif 25:36-8. 2007..Little attention is paid to the potential for harm to patients, and to the profession of medicine, from the widespread use of guidelines...
Continuous flow peritoneal dialysis: update 2012Richard Amerling
Division of Nephrology and Hypertension, Beth Israel Medical Center, New York, NY 10003, USA
Contrib Nephrol 178:205-15. 2012..Potential applications include daily home dialysis, treatment of acute renal failure in the ICU, ultrafiltration of ascites, and the wearable artificial kidney...
Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis populationWalead Latif
Beth Israel Medical Center, Albert Einstein College of Medicine, New York, New York, USA
Clin J Am Soc Nephrol 6:2470-7. 2011..Hyperuricemia is associated with hypertension, coronary artery disease, and chronic kidney disease. However, there are no specific data on the relationship of uric acid to cardiovascular disease in the chronic hemodialysis setting...
Extracorporeal strategies for the removal of middle moleculesJames F Winchester
Beth Israel Medical Center, New York, New York 10003, USA
Semin Dial 19:110-4. 2006..Factors influencing dialytic removal of LMWPs such as membrane characteristics, protein-membrane interactions, and solute removal mechanisms, as well as strategies to enhance clearance of these compounds are discussed...
Guidelines have done more harm than goodRichard Amerling
Division of Nephrology and Hypertension, Beth Israel Medical Center, New York, NY 10003, USA
Blood Purif 26:73-6. 2008..This all but guarantees many guidelines are obsolete by the time they are published. Guidelines are produced with industry support and recommendations often have a major impact on sales of industry products...
The 2006 K/DOQI guidelines for peritoneal dialysis adequacy are not adequateJames F Winchester
Division of Nephrology and Hypertension, Beth Israel Medical Center, 350 East 17th Street, New York, NY 10003, USA
Blood Purif 25:103-5. 2007..Body size has changed in the US and Canada over the last few decades and there are similar changes worldwide. We suggest that the minimum targets for peritoneal dialysis be reinstituted at the previous standard Kt/V(urea) of 2.0...
The potential application of sorbents in peritoneal dialysisJames F Winchester
Beth Israel Medical Center, New York, NY 10003, USA
Contrib Nephrol 150:336-43. 2006..Sorbents assist the process of peritoneal dialysate regeneration and have the potential to improve the efficiency of continuous flow peritoneal dialysis...
Three controversial issues in extracorporeal toxin removalDonald A Feinfeld
Division of Nephrology and Hypertension, Beth Israel Medical Center, New York, New York 10003, USA
Semin Dial 19:358-62. 2006..In the meantime, we must continue to use less than ideal evidence and our own experience in dealing with these controversial issues to guide our decision-making process...
Acute non-occlusive mesenteric ischemia of the small bowel in a patient started on hemodialysis: a case reportZachary Z Brener
Division of Nephrology, Beth Israel Medical Center, 1350 E, 17th Street, Baird Pav, 18th Floor, New York, NY, USA
Cases J 1:217. 2008..abstract:..
Nephrolithiasis: evaluation and managementZachary Z Brener
Nephrology Division, Department of Medicine, Beth Israel Medical Center, New York, NY 10003, USA
South Med J 104:133-9. 2011....
A quick and simple estimate of creatinine clearanceFarhan Ali
Division of Nephrology and Hypertension, Beth Israel Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA
J Nephrol 23:408-14. 2010..However, these equations require complex calculations and several parameters. We derived an equation to estimate creatinine clearance (eCCr) rapidly...
In-vitro myoglobin clearance by a novel sorbent systemViktoriya I Kuntsevich
Department of Medicine, Division of Nephrology and Hypertension, Beth Israel Medical Center, New York, New York 10003, USA
Artif Cells Blood Substit Immobil Biotechnol 37:45-7. 2009..X-Sorb appears to be an effective sorbent for myoglobin and warrants a trial in vivo to determine whether it is equally effective and safe...
Clinical benefit of preserving residual renal function in dialysis patients: an update for cliniciansZachary Z Brener
Department of Medicine, Beth Israel Medical Center, 350 E Seventeenth Street, Eighteenth Floor, New York, NY 10003, USA
Am J Med Sci 339:453-6. 2010..This article will review the evidence supporting the importance of RRF on outcome and outline potential strategies that may better preserve RRF in patients on dialysis...
Comments on the guideline debateRichard Amerling
Division of Nephrology and Hypertension, Beth Israel Medical Center, New York, NY 10003, USA
Clin J Am Soc Nephrol 2:208. 2007
Absence of NF-kappaB activation by a new polystyrene-type adsorbent designed for hemoperfusionElisa Menegatti
Scuola di Specializzazione di Patologia Clinica, Universita di Torino, Torino, Italia
Blood Purif 23:91-8. 2005..Molecular structure and chemical modifications of the surface beads of this cartridge should prevent exposure of dense hydrophobic surface sites to proteins, and avoid the major drawbacks of previous polystyrene-type adsorbent materials...
Middle molecules and small-molecular-weight proteins in ESRD: properties and strategies for their removalWilliam R Clark
NxStage Medical, Inc, Indiana University School of Medicine, Indianapolis, USA
Adv Ren Replace Ther 10:270-8. 2003....
Novel changes in beta2-microglobulin in dialysis patientsJames F Winchester
Clin Chem 51:1089-90. 2005
Effect of a novel adsorbent on cytokine responsiveness to uremic plasmaMarion D Morena
Department of Medicine, Tupper Research Institute, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA
Kidney Int 63:1150-4. 2003..CONCLUSION: The sorbent beads removed uremic solute(s) that prime monocytes to enhanced cytokine production. Removal of beta2M was efficient, and of native and AGE-modified middle molecules likely...
Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trialDonal N Reddan
Duke University Medical Center, Box 3646, Durham, NC 27710, USA
J Am Soc Nephrol 16:2162-9. 2005..The atypically low hospitalization and mortality rates for the conventional monitoring group suggest that these findings should be generalized to the US hemodialysis population with caution...
Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patientsJula K Inrig
Department of Medicine, Duke University Medical Center, Durham, NC 27705, USA
Am J Kidney Dis 50:108-18, 118.e1-4. 2007..This study seeks to define the relationship between IDWG and BP in prevalent hemodialysis subjects...
